Policy Brief
Published on 30 Jun 2023
Eliminating financial disincentives to living kidney donation – a call to action
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2023.1061342
- 2,379 views
- 2 citations
- Frontiers in Medicine
- Regulatory Science
- Articles
Type at least 3 characters
246 articles
Study Protocol
Published on 29 Jun 2023
Protocol for the development of a reporting guideline for clinical trials with integrated Chinese and western medicine interventions: the CONSORT extension for ICWM
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2023.1190560
- 3,928 views
Mini Review
Published on 28 Jun 2023
The composite quality score for the appraisal of prospective controlled clinical therapy trials in systematic reviews and its limits
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2023.1201951
- 1,445 views
- 3 citations
Correction
Published on 22 Jun 2023
Corrigendum: Factors influencing participation in COVID-19 clinical trials: a multinational study
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2023.1230259
- 771 views
Review
Published on 20 Jun 2023
Integrating qualitative interviews in drug development and the use of qualitative evidence in product labelling and health technology assessments: a review
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2023.1197529
- 6,306 views
- 1 citation
Methods
Published on 15 Jun 2023
Allocation concealment appraisal of clinical therapy trials using the extended Composite Quality Score (CQS-2)—An empirically based update
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2023.1176219
- 1,107 views
- 2 citations
Original Research
Published on 30 May 2023
Involvement of the European Medicines Agency in multi-stakeholder regulatory science research projects: experiences of staff members and project coordinators
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2023.1181702
- 3,102 views
- 2 citations
Opinion
Published on 25 May 2023
Legal, deontological, and ethical basis of the physician–minor patient care relationship
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2023.1186414
- 5,331 views
- 1 citation
Original Research
Published on 18 May 2023
Collaborative training of regulators as an approach for strengthening regulatory systems in LMICs: experiences of the WHO and Swissmedic
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2023.1173291
- 5,119 views
- 4 citations
Original Research
Published on 16 May 2023
Establishing a core dossier for multiple regulatory submissions: a case study in the Latin America region
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2023.1102452
- 4,789 views
Editorial
Published on 16 May 2023
Editorial: Reviews in: regulatory science
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2023.1206753
- 1,660 views
Original Research
Published on 09 May 2023
How about the evidence assessment tools used in education and management systematic reviews?
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2023.1160289
- 2,753 views
- 4 citations
Original Research
Published on 05 May 2023
Policy analysis in the field of rare diseases in China: a combined study of content analysis and Bibliometrics analysis
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2023.1180550
- 4,083 views
- 9 citations
Review
Published on 05 May 2023
Potency testing of cell and gene therapy products
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2023.1190016
- 28,541 views
- 17 citations
Original Research
Published on 20 Apr 2023
Situation analysis on the regulation of nanomedicines in Southern Africa
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2023.1098830
- 2,165 views
- 2 citations
Original Research
Published on 18 Apr 2023
Using AGREE II reporting checklist to evaluate the quality of Tuina clinical practice guidelines
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2023.961886
- 2,877 views
- 2 citations